Meld u aan

Linrong Lu

Shanghai Immune Therapy Institute

Renji Hospital, Shanghai Jiao Tong University School of Medicine

BIOGRAPHY

Linrong Lu has not added Biography.

If you are Linrong Lu and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Tespa1 negatively regulates FcεRI-mediated signaling and the mast cell-mediated allergic response.

The Journal of experimental medicine Dec, 2014 | Pubmed ID: 25422497

Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1.

The Journal of experimental medicine May, 2017 | Pubmed ID: 28400474

Phosphatase PP2A is essential for T17 differentiation.

Proceedings of the National Academy of Sciences of the United States of America Jan, 2019 | Pubmed ID: 30593560

Protein phosphatase 2A has an essential role in promoting thymocyte survival during selection.

Proceedings of the National Academy of Sciences of the United States of America Jun, 2019 | Pubmed ID: 31152132

Thymic-specific regulation of TCR signaling by Tespa1.

Cellular & molecular immunology Dec, 2019 | Pubmed ID: 31316154

Dual roles of misshapen/NIK-related kinase (MINK1) in osteoarthritis subtypes through the activation of TGFβ signaling.

Osteoarthritis and cartilage Jan, 2020 | Pubmed ID: 31647983

Thymocyte selection: From signaling to epigenetic regulation.

Advances in immunology , 2019 | Pubmed ID: 31699214

Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus.

Cellular & molecular immunology Aug, 2021 | Pubmed ID: 32472023

Mobilizing ER IP3 receptors as a mechanism to enhance calcium signaling.

Cellular & molecular immunology Sep, 2021 | Pubmed ID: 34253857

Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages.

Cellular & molecular immunology Oct, 2021 | Pubmed ID: 34480147

CAR-T cell therapy: new hope for systemic lupus erythematosus patients.

Cellular & molecular immunology Dec, 2021 | Pubmed ID: 34737415

NPAT Supports CD8 Immature Single-Positive Thymocyte Proliferation and Thymic Development.

Journal of immunology (Baltimore, Md. : 1950) Sep, 2022 | Pubmed ID: 35922064

Protein phosphatase 2A propels follicular T helper cell development in lupus.

Journal of autoimmunity Apr, 2023 | Pubmed ID: 37001432

GRP75-dependent mitochondria-ER contacts ensure cell survival during early mouse thymocyte development.

Developmental cell Oct, 2024 | Pubmed ID: 38981469

INSTITUTIONS

Renji Hospital, Shanghai Jiao Tong University School of Medicine

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

JOVE ARTICLES

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

Zejin Cui^*,1,

Pengkun Yuan^*,2,

Zhishan Zhao^*,1,

Fan Zhao³,

Linrong Lu^1,3

¹Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine,

²Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University,

³Institute of Immunology and Department of Rheumatology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

Immunology and Infection

Privacy

Gebruiksvoorwaarden

Beleid

Neem contact met ons op.

Aanbevelen aan bibliotheek

JoVE Nieuwsbrieven

Onderzoek

JoVE Journal
Methoden Collecties
JoVE Encyclopedia of Experiments
Archiveren

Onderwijs

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Faculteitssite

Auteurs

Overzicht
Publicatieproces
Redactieraad
Omvang en beleid
Collegiale beoordeling
VEELGESTELDE VRAGEN
Verzenden

Bibliothecarissen

Overzicht
Getuigenissen
Abonnementen
Toegang
Middelen
Bibliotheek Adviesraad
VEELGESTELDE VRAGEN

Over JoVE

Overzicht
Leiderschap
Blog
JoVE Help Center
JoVE Sitemap

Linrong Lu

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Shanghai Immune Therapy Institute

Renji Hospital, Shanghai Jiao Tong University School of Medicine

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

Shanghai Immune Therapy Institute